Fate Therapeutics (FATE) PT Raised to $33 at Wedbush
Tweet
Share
E-mailGet Alerts FATE Hot Sheet
Price: $2.33 -4.9%
Rating Summary:
11 Buy, 13 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
11 Buy, 13 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Wedbush analyst David Nierengarten raised the price target on Fate Therapeutics (NASDAQ: FATE) to $33.00 (from $29.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
- Progyny (PGNY) PT Raised to $30 at JPMorgan
- Advance Auto Parts (AAP) PT Lowered to $55 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
